Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07523971) titled 'Efficacy and Safety of Pitavastatin/Ezetimibe in Dyslipidemia Patients With Metabolic Syndrome: An Observational Study' on April 5.
Study Type: Observational [Patient Registry]
Primary Sponsor: JW Pharmaceutical
Condition:
Dyslipidemias
Recruitment Status: Recruiting
Date of First Enrollment: June 25, 2025
Target Sample Size: 10000
Countries of Recruitment:
South Korea
To know more, visit https://clinicaltrials.gov/study/NCT07523971
Published by HT Digital Content Services with permission from Health Daily Digest....